Contract notice: General anti-infectives Tender - 27725902
Tender notice from Macedonia, published on 17 Oct 2018.
Executive Summary
The PUBLIC HEALTH INSTITUTE UNIVERSITY CLINIC FOR CLINICAL BIOCHEMISTRY — SKOPJE has issued a Tender notice for the procurement of a Contract notice: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents in the Macedonia. This Tender notice was published on 17 Oct 2018 and is scheduled to close on 15 Oct 2018, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 27725902, while the tender notice number is 455750-2018 and Register on the platform.
Key facts
Summary
Contract notice: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Object of the contract General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents Description: Contract notice: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents Authority Type: Other Contact Nature: Supplies Procedure: Open procedure Document: Contract notice Regulation: Other Award criteria: Lowest price CPV code: 33650000, 33650000 CPV Description: Reagents, Calibrators, Controls and Consumables Compatible for Immunology Anayzer architect c400 "or the equivalent" General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents. Part 1: Reagents for detecting glucose in serum for architect c4000 or equivalent; Part 2: Reagents for detecting glycated hemoglobin in whole-blood for device architect c4000 or equivalent; Part 3: Reagents for detecting urea in serum for device architect c4000 or equivalent; Part 4: Reagents for detecting creatinine in serum for device architect c4000 or equivalent; Part 5: Reagents for detecting uric acid in serum for device architect c4000 or equivalent; Part 6: Reagents for detecting total bilirubin in serum or plasma for device architect c4000 or equivalent; Part 7: Reagents for detecting direct bilirubin in serum or plasma for device architect c4000 or equivalent; Part 8: Reagents for detecting total protein in serum or plasma for device architect c4000 or equivalent; Part 9: Reagents for detecting albumin in serum or plasma for device architect c4000 or equivalent; Part 10: Reagents for detecting proteins in urine or cerebrospinal liquid for device architect c4000 or equivalent; Part 11: Reagents for detecting alkaline phosphatase in serum or plasma for device architect c4000 or equivalent; Part 12: Reagents for detecting amylase in serum, plasma or urine for device architect c4000 or equivalent; Part 13: Reagents for detecting aspartate aminotransferase in serum or plasma for device architect c4000 or equivalent; Part 14: Reagents for detecting alanine aminotransferase in serum or plasma for device architect c4000 or equivalent; Part 15: Reagents for detecting creatine kinase in serum or plasma for device architect c4000 or equivalent; Part 16: Reagents for detecting lactate dehydrogenase in serum or plasma for device architect c4000 or equivalent; Part 17: Reagents for detecting gamma glutamyl transferase in serum or plasma for device architect c4000 or equivalent; Part 18: Reagents for detecting calcium in serum, plasma or urine for device architect c4000 or equivalent; Part 19: Reagents for detecting phosphorus in serum, plasma or urine for device architect c4000 or equivalent; Part 20: Reagents for detecting magnesium in serum, plasma or urine for device architect c4000 or equivalent; Part 21: Reagents for detecting ferrum in serum or plasma for device architect c4000 or equivalent; Part 22: Reagents for detecting unsaturated iron binding capacity in serum or plasma for device architect c4000 or equivalent; Part 23: Reagents for detecting triglycerides in serum or plasma for device architect c4000 or equivalent; Part 24: Reagents for detecting total cholesterol in serum or plasma for device architect c4000 or equivalent; Part 25: Reagents for detecting high density lipoprotein (HDL) for device architect part or equivalent; Part 26: Reagents for detecting lactic acid in serum or plasma for device architect c4000 or equivalent; Part 27: Reagents for quantitative detection of immunoglobulin A (IgA) for biochemical analyzer architect c4000 or equivalent; Part 28: Reagents for quantitative detection of immunoglobulin G (IgG) for biochemical Analyzer architect c4000 or equivalent; Part 29: Reagents for quantitative detection of immunoglobulin M (IgM) for biochemical Analyzer architect c4000 or equivalent; Part 30: Reagents for quantitative detection of protein from the complement system C3 for Biochemical analyzer architect c4000 or equivalent; Part 31: Reagents for quantitative detection of protein from the complement system C4 for Biochemical analyzer architect c4000 or equivalent; Part 32: Reagents for detecting C-reactive protein in serum or plasma for device architect c4000 or equivalent; Part 33: Reagents for detecting Anti-streptolysin O in serum or plasma for integrated system architect c4000 or equivalent; Part 34: Reagents for detecting rheumatoid factor in serum or plasma for integrated system architect c4000 or equivalent; Part 35: Electrolyte kit, for device architect c4000 or equivalent; Part 36: ?cid solution for cuvette washing for device architect c4000 or equivalent; Part 37: Alkaline solution for cuvette washing for device architect c4000 or equivalent; Part 38: Additive for prevention contamination of water bath for device architect C4000 or equivalent; Part 39: Washing solution for needles A (detergent A) for device architect c4000 or equivalent; Part 40: Washing solution for needles B (detergent B) for device architect c4000 or equivalent; Part 41: Electrolyte reference fluid for device architect c4000 or equivalent; Part 42: Concentrated electrolyte diluent for device architect c4000 or equivalent; Part 43: Electrolytic module cleaning solution for device architect c4000 or equivalent; Part 44: Multifunction calibrators for calibrating of the minimum parameters as listed here: — Glucose, urea, — creatinine, — urine acid, — total protein, — albumin, — alkaline phosphatase, — acid, — Phosphatase, — amylase, — aspartate aminotransferase, — creatine kinase, — lactate dehydrogenase, — Gamma glutamyl transferase, — calcium, — phosphorus, — magnesium, ferrum, — capacity of binding, — unsaturated iron, — triglycerides, — total cholesterol and lactate for device architect c4000 or equivalent; Part 45: Calibrator for glycated hemoglobin for device architect c4000 or equivalent; Part 46: Calibrator for total and direct bilirubin for device architect c4000 or equivalent; Part 47: Multi-calibrator for specific protein for device architect c4000 or equivalent; Part 48: Calibrator for protein in urine for device architect c4000 or equivalent; Part 49: Calibrator for electrolyte in serum for device architect c4000 or equivalent; Part 50: Calibrator for electrolyte in urine for device architect c4000 or equivalent; Part 51: Calibrator for high-density lipoprotein for device architect c4000 or equivalent; Part 52: Calibrator for C-reactive protein for device architect c4000 or equivalent; Part 53: Calibrator for antistreptolysin for device architect c4000 or equivalent; Part 54: Calibrator for rheumatoid factor for device architect c4000 or equivalent; Part 55: Cuvettes for serum and plasma, plastic 48, 87 mm high, aperture diameter 7, 55 mm; And a cone shaped bottom with a diameter of 5, 39 mm (standard deviations of all dimensions of +/-1 %) for device architect c4000 or equivalent; Part 56: Control of: — glucose, — urea, — creatinine, — urin acid, — total and direct bilirubin, — total protein, — albumin, — alkaline phosphatase, — acid phosphatase, — amylase, — aspartate, — Aminotransferase, — alanine aminotransferase, — creatine kinase, — lactate dehydrogenase, — gamma, — Glutamyl transferase, — cholinesterase, — calcium, — phosphorus, — magnesium, — ferrum, — capacity for binding of unsaturated iron, — triglycerides, — total high-density cholesterol and lipoprotein (HDL), lactate and lipase level 1 for device architect c4000 or equivalent. Part 57: Control of glucose, urea, creatinine, urine acid, total and direct bilirubin; Part 58: Control of C-reactive protein control; protein form the complement system C3 and C4; immunoglobulin A, G, M; rheumatoid factor and Anti-streptolysin O level 1 for device architect c4000 or equivalent; Part 59: Control of C-reactive protein control; protein form the complement system C3 and C4; immunoglobulin A, G, M; rheumatoid factor and Anti-streptolysin O level 2 for device architect c4000 or equivalent; Part 60: Control of C-reactive protein control; protein form the complement system C3 and C4; immunoglobulin A, G, M; rheumatoid factor and Anti-streptolysin O level 3 for device architect c4000 or equivalent; Part 61: Control of glycated hemoglobin HbA1c level 1 for device architect C4000 or equivalent; Part 62: Control of glycated hemoglobin HbA1c level 2 for device architect C4000 or equivalent; Part 63: Control of glycated hemoglobin HbA1c level 3 for device architect C4000 or equivalent; Part 64: Urine protein control level 1 for device architect c4000 or equivalent; Part 65: Urine protein control level 2 for device architect c4000 or equivalent. Guarantee for quality execution of the contract: A condition for signing a contract with the most favourable economic operator is to provide a bank guarantee by the tenderer who is selected as the most favourable as well as for implementation of the contract in a quality manner in amount of 5 % of the value of the contract, VAT excluded. — document for registered activity — DRD form or certificate of registered activity, — decision for wholesale trade with medical supplies under the law on medicines and medical appliances, — a statement by the economic operator that it has not been imposed a legally valid court decision for participation in criminal organization, corruption, fraud or money laundering for the last 5 years, — a certificate by a competent authority that a bankruptcy procedure has not been initiated, — a certificate by a competent authority that a liquidation procedure has not been initiated, — a certificate by a competent authority from the country where that economic operator is registered for paid taxes, contributions and other public duties, — a certificate by the Register of sentences for committed crimes of legal entities that a secondary sentence prohibition on participation in open call procedures, awarding public procurement contracts and contracts for public private partnership, has not been imposed, — a certificate by the Register of sentences for committed crimes of legal entities that a secondary sentence, temporary or permanent prohibition on performing a certain activity has not been imposed and — a certificate that a misdemeanor sanction resulting in prohibition for practicing profession, performing activity or —— EN standard form 02 — contract notice 6/16; —— EN standard form 02 — contract notice 7/43. Duty, i.e. temporary prohibition for performing a particular activity has not been imposed by a legally valid court decision. Internet address (URL): Directive: Classical Directive (2004/18/EC)
The bid deadline for Contract notice: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents was 15 Oct 2018. Bidding is closed.
This tender has been issued by PUBLIC HEALTH INSTITUTE UNIVERSITY CLINIC FOR CLINICAL BIOCHEMISTRY — SKOPJE in Macedonia.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is Self Financed
The tender is classified under the following CPV code(s): 33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 27725902. The purchaser document reference is 455750-2018.